NEW DEVICE FOR MONITORING LITHIASIS
The Centre for Sensors, Instruments and Systems Development (CD6 UPC) has worked on the development of a prototype of a device that enables patients with renal lithiasis (colloquially known as kidney stones) to track their disease daily at a cost that is 30 times less than today. The electronics and the programming of the device have been developed by the Center CD6 UPC for the company Global Health Home Devices, which is directed by Rosendo Garganta, a former UPC student.
The CD6 UPC, has participated in the development of a prototype self-diagnosis for patients with kidney stones.
It is a device that allows you suffer from this disease make a pot out of newspaper to the hospital by a urine test reveal whether the problem (or the presence of kidney stones inside the kidney or of the urinary tract) persists. With this new device will begin to occur in a few months, the public health systems could save a significant amount of money because the tests are done by patients themselves and outside the health centers at a cost significantly lower than teams current, designed for use strictly professional.
Leading the development of this prototype is Rosendo Garganta: graduate in Industrial Electronics and Control Engineering at the Universitat POlitècnica de Catalunya·BarcelonaTech, in both cases with the number 1 in their respective promotions, this 28-year old directed the company Global Home Health Devices, based in Mataró, Barcelona.
The prototype and testing phases has been presented in an international conference on biotechnology and its creator has already patented worldwide.
The electronics and the programming of the device have been carried out in CD6 UPC. The project, led by Dr. Jesus Caum, involved in electronics design, firmware development and prototyping for a sealed sensor package in order to measure the pH of the urine. The sensor has been developed in collaboration with the Chemical Transducers Group of the Institute of Microelectronics (CNM, CSIC).
The key to a team substantially cheaper than those managed in hospitals is the use of silicon rather than glass, allowing lower the cost per unit of $ 3,000 to just under 100. The price and ease of use of the device (three icons with many other colors, green, white and red markers indicate if the patient is at normal levels, below or above, respectively) expects its creator His arrival in the market in 2014 is a success.